| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-22 |
| filingDate |
1999-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_356c9bb2006e0b18ed64c4a4cf41437e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e5c3fce061a231d4354ef2479d7939e |
| publicationDate |
2000-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2000080030-A |
| titleOfInvention |
Granuloma prevention / treatment agent |
| abstract |
(57) [Problem] To provide a pharmaceutical composition having an excellent preventive / therapeutic effect on granuloma such as laryngeal granuloma. SOLUTION: General formula (Ia): Wherein R 1 and R 2 are either a methyl group or a methoxy group, attached R 1 and R 2 together with R 1 and R 2 - Shows CH = CH-CH = CH-. R 3 represents a phenyl, naphthyl or thienyl group which may be substituted, R 4 represents a carboxyl group or a group which can be converted into a carboxyl group in vivo, and n represents an integer of 3 to 15. And / or a hydroquinone derivative thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104215031-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0195938-A1 |
| priorityDate |
1998-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |